| 序号 |
标题 |
次数 |
作者 |
发布时间 |
| 175681 |
CAS:10402-53-6 Eprazinone (dihydrochloride) 盐酸依普拉酮 原研药中间体供应 |
290 |
kx |
2024-04-03 |
| 175682 |
Poly(vinyl phosphonate)sodium salt，PVPhos，聚乙烯基膦酸酯钠 |
309 |
h |
2024-04-03 |
| 175683 |
CAS:1004316-88-4 Cobicistat 可比司他 新药中间体工艺 |
315 |
zcy |
2024-04-03 |
| 175684 |
CAS:3166-62-9 Methylbenactyzium Bromide 溴甲乙胺痉平 药物分子开发 |
200 |
kx |
2024-04-03 |
| 175685 |
mPEG-P(D)La，甲氧基-聚乙二醇-聚D-丙交酯 |
242 |
h |
2024-04-03 |
| 175686 |
mPEG-b-PLGA，甲氧基聚乙二醇-b-聚(D,L-丙交酯-co-乙交酯) |
398 |
h |
2024-04-03 |
| 175687 |
CAS:1009119-64-5 Daclatasvir 达卡他韦 药物分子开发 |
330 |
zcy |
2024-04-03 |
| 175688 |
CAS:8047-67-4 Iron sucrose 蔗糖铁 原料药研发 |
330 |
kx |
2024-04-03 |
| 175689 |
5,10,15,20-四[4-(2-甲基-1H-咪唑基)苯基] -21H,23H-卟吩，定制服务 |
246 |
axc |
2024-04-03 |
| 175690 |
Methoxy poly(ethylene glycol)-poly(5-benzyloxy-trimethylene carbonate) |
225 |
h |
2024-04-03 |
| 175691 |
CAS:1009119-65-6 Daclatasvir (dihydrochloride) 达卡他韦二盐酸盐 药物分子开发 |
343 |
zcy |
2024-04-03 |
| 175692 |
CAS:213997-73-0 Norvancomycin (hydrochloride) 盐酸去甲万古霉素 批量合成 |
244 |
kx |
2024-04-03 |
| 175693 |
CAS:1072833-77-2 Ixazomib 艾沙佐米 新药中间体KG级 |
229 |
zcy |
2024-04-03 |
| 175694 |
CAS:61477-96-1 Piperacillin 哌拉西林 工艺优化 |
273 |
kx |
2024-04-03 |
| 175695 |
CAS:842133-18-0 Canagliflozin 卡格列净 新药中间体工艺 |
254 |
zcy |
2024-04-03 |
| 175696 |
CAS:16846-24-5 Josamycin 交沙霉素 化合物合成 |
216 |
kx |
2024-04-03 |
| 175697 |
CAS:960404-48-2 Dapagliflozin ((2S)-1,2-propanediol, hydrate) 达格列净一水丙二醇 原研药中间体供应 |
389 |
zcy |
2024-04-03 |
| 175698 |
2HTCNPP，14609-51-9，5,10,15,20-四(4-氰基苯基)卟啉，四氰基苯基卟啉 |
299 |
axc |
2024-04-03 |
| 175699 |
CAS:24916-51-6 Acetylspiramycin 乙酰螺旋霉素 路线研究 |
220 |
kx |
2024-04-03 |
| 175700 |
CAS:461432-26-8 Dapagliflozin 达格列净 药物分子开发 |
427 |
zcy |
2024-04-03 |
| 175701 |
mPEG-P(5BZTMC)，聚乙二醇-聚(5-苄氧基-三亚甲基碳酸酯) 两亲性二嵌段共聚物 |
372 |
h |
2024-04-03 |
| 175702 |
CAS:52093-21-7 Micronomicin 小诺霉素 中试供应 |
210 |
kx |
2024-04-03 |
| 175703 |
Poly(ethylene glycol)-b-poly(D,L-lactic acid)-decyl，聚乙二醇-聚DL-乳酸-癸基 |
240 |
h |
2024-04-03 |
| 175704 |
cas14609-51-9，5,10,15,20-四(4-氰基苯基)卟啉，Meso-Tetra(4-cyanobenzyl)porphine |
274 |
axc |
2024-04-03 |
| 175705 |
PEG-PDLLA-Decyl，聚乙二醇-聚DL-乳酸-癸基 |
265 |
h |
2024-04-03 |
| 175706 |
CAS:404-86-4 Capsaicin 辣椒碱 新药中间体放大 |
225 |
zcy |
2024-04-03 |
| 175707 |
CAS:35457-80-8 Midecamycin 麦迪霉素 小试供应 |
317 |
kx |
2024-04-03 |
| 175708 |
间-四(对 - 溴苯基)卟啉，cas29162-73-0，meso-Tetra (p-bromophenyl) porphine，5,10,15,20-四(4-溴苯基)卟啉 |
297 |
axc |
2024-04-03 |
| 175709 |
Poly(DL-Lactide)-b-Poly(ethylene glycol)-Maleimide，聚乳酸聚乙二醇马来酰亚胺 |
243 |
h |
2024-04-03 |
| 175710 |
CAS:146464-95-1 Pralatrexate 普拉曲沙 新药中间体中试 |
255 |
zcy |
2024-04-03 |
| 175711 |
CAS:14897-39-3 Rifamycin (sodium) 利福霉素钠盐 公斤级 |
300 |
kx |
2024-04-03 |
| 175712 |
PLA-PEG-Mal，聚乳酸聚乙二醇马来酰亚胺 |
246 |
h |
2024-04-03 |
| 175713 |
CAS:1809249-37-3 Remdesivir 瑞德西韦 原研药中间体供应 |
242 |
zcy |
2024-04-03 |
| 175714 |
cas160240-15-3，5,10,15,20-四(4-乙炔基苯基)卟啉，分子量：710.821 |
251 |
axc |
2024-04-03 |
| 175715 |
CAS:56839-43-1 Eperisone (hydrochloride) 盐酸乙哌立松 化合物优化 |
300 |
kx |
2024-04-03 |
| 175716 |
Methoxy poly(ethylene glycol)-b-poly(lactide)-Pyridine dithioethylamide endcap，甲氧基聚乙二醇聚乳酸巯基吡啶 |
226 |
h |
2024-04-03 |
| 175717 |
mPEG-PLA-OPSS，甲氧基聚乙二醇聚乳酸巯基吡啶 |
243 |
h |
2024-04-03 |
| 175718 |
CAS:1446261-44-4 Pamiparib 药物分子开发 |
226 |
zcy |
2024-04-03 |
| 175719 |
cas22112-84-1，5,10,15,20-四(4-氨基苯)-21H,23H-卟啉，分子量：674.794 |
275 |
axc |
2024-04-03 |
| 175720 |
CAS:2921-57-5 Methylprednisolone succinate 甲基泼尼松龙琥珀酸酯 线路优化 |
273 |
kx |
2024-04-03 |
| 175721 |
CAS:165800-03-3 Linezolid 利奈唑胺 批量生产 |
256 |
zcy |
2024-04-03 |
| 175722 |
cas186697-34-7，5,10,15,20-四[4-(2H-四唑-5-基)苯基] -21H,23H-卟吩，分子量：886.8858 |
265 |
axc |
2024-04-03 |
| 175723 |
CAS:74536-44-0 Metadoxine 美他多辛 工艺放大 |
287 |
kx |
2024-04-03 |
| 175724 |
CAS:2137030-98-7 Ensartinib (dihydrochloride) 恩萨替尼盐酸盐 大包装 |
326 |
zcy |
2024-04-03 |
| 175725 |
四醛基苯基卟啉，cas150805-46-2，分子量：726.776，分子式：C48H30N4O4 |
742 |
axc |
2024-04-03 |
齐岳微信公众号
官方微信
库存查询